PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN

被引：371

作者：

KUPFER, A

PREISIG, R

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 26卷 / 06期

关键词：

D O I：

10.1007/BF00541938

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：753 / 759

页数：7

相关论文

共 35 条

[1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS
ALDABBAGH, SG
IDLE, JR
SMITH, RL
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164
[2] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[3] BUTLER TC, 1952, J PHARMACOL EXP THER, V104, P299
[4] BUTLER TC, 1956, J PHARMACOL EXP THER, V117, P160
[5] IMPAIRMENT OF PHENYTOIN PARA-HYDROXYLATION AS A CAUSE OF SEVERE INTOXICATION
DEWOLFF, FA
VERMEIJ, P
FERRARI, MD
BURUMA, OJS
BREIMER, DD
[J]. THERAPEUTIC DRUG MONITORING, 1983, 5 (02) : 213 - 215
[6] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[7] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
EICHELBAUM, M
BERTILSSON, L
SAWE, J
ZEKORN, C
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
[8] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[9] ACUTE INTOXICATION WITH 5,5-DIPHENYLHYDANTOIN (DILANTIN) ASSOCIATED WITH IMPAIRMENT OF BIOTRANSFORMATION - PLASMA LEVELS AND URINARY METABOLITES - STUDIES IN HEALTHY VOLUNTEERS
GERBER, N
LYNN, R
OATES, J
[J]. ANNALS OF INTERNAL MEDICINE, 1972, 77 (05) : 765 - +
[10] POLYMORPHISMS OF OXIDATION AT CARBON CENTERS OF DRUGS AND THEIR CLINICAL SIGNIFICANCE
IDLE, JR
SMITH, RL
[J]. DRUG METABOLISM REVIEWS, 1979, 9 (02) : 301 - 317

← 1 2 3 4 →